Real-world clinical experience with weekly somatrogon in pediatric growth hormone deficiency: A French longitudinal study with some unexpected clinical observations
Annales d'Endocrinologie · 2026-11 · 87 (6) · 102590
DOI: 10.1016/j.ando.2026.102590 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annales d'Endocrinologie, 2026-11. Verfasst von Isabelle Flechtner und 19 weiteren Autor:innen. Beteiligte Einrichtung: Association Française des Pédiatres Endocrinologues Libéraux (AFPEL), 150, rue de Charenton, 72012 Paris, France. Electronic address: isabelle.flecht…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: To evaluate the effectiveness, safety and metabolic impact of weekly somatrogon in pediatric patients with growth hormone deficiency (GHD) in a real-world clinical setting. DESIGN: A retrospective and prospective observational cohort study was conducted by the French Association of Private Pediatric Endocrinologists (AFPEL), up to 24 months' follow-up. Data were collected from between April to December 2025 for growth hormone deficient patients who started somatrogon treatment between May 2023 and December 2025, followed in private practice by an AFPEL member in all regions of France. METHODS: A total of 163 children (mean age 9.7 years) were included: 92 treatment-naive and 71 switching from daily growth hormone (dGH). Growth parameters, BMI z-scores, IGF1 levels and adverse events were monitored. Multivariate regression was used to identify predictors of change in BMI. RESULTS: Height growth during the first year was 10.0cm/year in naïve and 7.0cm/year in switch patients. A significant biphasic increase in BMI z-score was observed (mean gain +0.81 SD; P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Association Française des Pédiatres Endocrinologues Libéraux (AFPEL), 150, rue de Charenton, 72012 Paris, France. Electronic address: isabelle.flechtner@aphp.fr.
- Association Française des Pédiatres Endocrinologues Libéraux (AFPEL), 150, rue de Charenton, 72012 Paris, France.
Zitieren
APA
Flechtner, I., Brue, C., Gastaud, F., Benoit, M. L., Cuny, A., Gérard, M., Bouillo, M., Auger, J., Chatelais, L., Castaings-Carlioz, C., Beaufils, E., Zenaty, D., Vignon-Savoye, C., Dupeux, M., Daval-Cote, M., Berthelon, K., Guemas, I., Casamayor, I., Dealberti, P., & Puel, O. (2026). Real-world clinical experience with weekly somatrogon in pediatric growth hormone deficiency: A French longitudinal study with some unexpected clinical observations. Annales d'Endocrinologie, 87(6), 102590. https://doi.org/10.1016/j.ando.2026.102590
Vancouver
Flechtner I, Brue C, Gastaud F, Benoit ML, Cuny A, Gérard M, et al. Real-world clinical experience with weekly somatrogon in pediatric growth hormone deficiency: A French longitudinal study with some unexpected clinical observations. Annales d'Endocrinologie. 2026;87(6):102590. doi:10.1016/j.ando.2026.102590
BibTeX
@article{Flechtner2026,
author = {Flechtner, Isabelle and Brue, Catherine and Gastaud, Frédérique and Benoit, Marie-Lucile and Cuny, Ariane and Gérard, Maxime and Bouillo, Myriam and Auger, Julie and Chatelais, Livie and Castaings-Carlioz, Céline and Beaufils, Emily and Zenaty, Delphine and Vignon-Savoye, Capucine and Dupeux, Marion and Daval-Cote, Melanie and Berthelon, Karen and Guemas, Isabelle and Casamayor, Isabelle and Dealberti, Prisca and Puel, Olivier},
title = {Real-world clinical experience with weekly somatrogon in pediatric growth hormone deficiency: A French longitudinal study with some unexpected clinical observations},
journal = {Annales d'Endocrinologie},
year = {2026},
volume = {87},
number = {6},
pages = {102590},
doi = {10.1016/j.ando.2026.102590}
}
EUVIMED